By Tokio X'press flu, 1.Human Capital, Health & Safety, 1.Product Liability, Product Safety & Quality, Insuring Health & Demographic Risk, Access to Health Care, Drugs, Pharmaceutical
COVID-19: Appili、米国でファビピラビル治験:第3相試験募集(動画): Appili Provides Enrollment Update for Phase 3 PRESECO Trial Favipiravir: Appili Therapeutics提供了其PRESECO第三阶段试验的注册更新